Comments on: New Nonprofit Vaccine R&D, with love from Novartis http://blog.pharmexec.com/2008/02/22/new-nonprofit-vaccine-rd-with-love-from-novartis/ The Business of Pharmaceuticals Wed, 08 Feb 2012 14:53:10 -0500 hourly 1 By: Sameer Nanda http://blog.pharmexec.com/2008/02/22/new-nonprofit-vaccine-rd-with-love-from-novartis/comment-page-1/#comment-197 Sameer Nanda Mon, 03 Mar 2008 18:02:42 +0000 http://blog.pharmexec.com/2008/02/22/new-nonprofit-vaccine-rd-with-love-from-novartis/#comment-197 Definitely these are good signs. However, looking purely in a business/ profitability angle, it makes sense to start concentrating on therapeutic areas related to diseases in developing countries because : 1. Huge patient base, coupled with growing economy will make these countries greener pastures. 2. Collaboration and cross pollination across research areas and people will always help new science to grow. 3. Bacterial infections, specially community acquired and hospital acquired resistant infections will be important areas of research, irrespective of geography. 4. Low cost research in developing countries can provide a "solid platform for further research" in many related areas. With a pure business perspective, it is debatable whether the time is ripe enough!! However, sooner or later things will start rolling..... - Sameer Definitely these are good signs. However, looking purely in a business/ profitability angle, it makes sense to start concentrating on therapeutic areas related to diseases in developing countries because :

1. Huge patient base, coupled with growing economy will make these countries greener pastures.

2. Collaboration and cross pollination across research areas and people will always help new science to grow.

3. Bacterial infections, specially community acquired and hospital acquired resistant infections will be important areas of research, irrespective of geography.

4. Low cost research in developing countries can provide a “solid platform for further research” in many related areas.

With a pure business perspective, it is debatable whether the time is ripe enough!! However, sooner or later things will start rolling…..

- Sameer

]]>